
# Enum: ReasonOffEnum




URI: [https://w3id.org/pcdc/model/ReasonOffEnum](https://w3id.org/pcdc/model/ReasonOffEnum)


## Other properties

|  |  |  |
| --- | --- | --- |

## Permissible Values

| Text | Description | Meaning | Other Information |
| :--- | :---: | :---: | ---: |
| Death | Specifies whether the life of an entity has ceased. | ncit:C93546 |  |
| Lost to Follow-Up | The subject was not available for follow-up procedures. | ncit:C70740 |  |
| Completion of Follow-Up | The follow-up protocols were completed. | ncit:C178071 |  |
| Completion of Planned Therapy | The end of the planned treatment. | ncit:C168935 |  |
| Physician Decision | A position, opinion or judgment reached after consideration by a physician with reference to subject. | ncit:C48250 |  |
| Ineligible | The state or quality of being disqualified by law, rule, or provision. | ncit:C40412 |  |
| Withdrawal of Consent | When the permission to do something is rescinded or withdrawn. | ncit:C48271 |  |
| Subject/Guardian Refused Further Treatment | The subject or their guardian has refused further treatment. | ncit:C91752 |  |
| Subject Non-Compliance | The subject or their guardian has refused further treatment. | ncit:C168934 |  |
| Disease Progression | The worsening of a disease over time. | ncit:C17747 |  |
| Relapse | The return of a disease after a period of remission. | ncit:C38155 |  |
| Adverse Event | Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s). | ncit:C41331 |  |
| Secondary Malignancy | A malignant neoplasm that arises from a pre-existing lower grade lesion, or as a result of a primary lesion that has spread to secondary sites, or due to a complication of a cancer treatment. | ncit:C4968 |  |
| Study Discontinuation | The act of concluding participation by an enrolled subject prior to completion of all protocol-required elements in a trial. NOTE: Four categories of discontinuation are distinguished: a) dropout: Active discontinuation by a subject (also a noun referring to such a discontinued subject); b) investigator initiated discontinuation (e.g., for cause); c) loss to follow-up: cessation of participation without notice or action by the subject; d) sponsor initiated discontinuation. Note that subject discontinuation does not necessarily imply exclusion of subject data from analysis. "Termination of subject" has a history of synonymous use, but is now considered nonstandard. [After ICH E3, section 10.1 and FDA Guidance for Industry: Submission of Abbreviated Reports & Synopses in Support of Marketing Applications, IV A] | ncit:C142444 |  |
| Failure to Attain Remission | Remission status was not attained. | ncit:C178072 |  |
| Other | Different than the one(s) previously specified or mentioned. | ncit:C17649 |  |
| Unknown | Reported as unknown by the data contributor. | ncit:C17998 |  |
| Not Reported | Not provided or available. | ncit:C43234 |  |

